Avoids Serious Complications In patients with severe anaemia, intensive treatment with B12 may result in a sudden drop in potassium (hypokalaemia), which can cause muscle weakness or an irregular heartbeat
Reported Limitations and Considerations in GHK-Cu Research Gaps in the Current Evidence Base Despite a substantial pre-clinical record, GHK-Cu lacks large-scale human clinical trial data for most reported applications
Effects of discontinuation of growth hormone treatment on body composition and metabolism
If the treatment is inadequate due to poor understanding of B12 metabolism, and symptoms return as a result, that's due to poor research/lack of adequate knowledge on how to treat B12 deficiency properly in PA
Wilsons disease) Active cancer or ongoing chemotherapy Severe liver or kidney disease Known hypersensitivity to copper peptides Drug interactions There are no well-established drug interaction studies for injectable GHK-Cu
This doesnt mean that every compound should always be combined without thought